Tower Research Capital LLC (Trc) Nephros Inc Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Nephros Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,791 shares of NEPH stock, worth $4,102. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,791
Previous 3,673
24.01%
Holding current value
$4,102
Previous $7,000
42.86%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding NEPH
# of Institutions
18Shares Held
4.28MCall Options Held
0Put Options Held
0-
Wexford Capital LP Greenwich, CT3.6MShares$5.29 Million1.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA202KShares$296,9310.0% of portfolio
-
Bard Associates Inc Chicago, IL172KShares$253,3850.11% of portfolio
-
Geode Capital Management, LLC Boston, MA85.2KShares$125,3160.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL57.2KShares$84,0980.0% of portfolio
About NEPHROS INC
- Ticker NEPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 10,318,800
- Market Cap $15.2M
- Description
- Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water ...